Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.05 -0.08 (-1.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Return on Capital Employed [ROCE] (2014 - 2025)

Updated

Corbus Pharmaceuticals Holdings (CRBP) reported Return on Capital Employed [ROCE] of -75.77% for Q3 2025, down 44.21 percentage points from -31.56% a year earlier and down 19.52 percentage points from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Return on Capital Employed [ROCE] (2014 - 2025) Analysis & Trends

For FY2024, Corbus Pharmaceuticals Holdings posted Return on Capital Employed [ROCE] of -60.71%, up 232.05 percentage points from FY2023.

  • Return on Capital Employed [ROCE] has a five-year change of +524.39 percentage points (FY2019 to FY2024).
  • By year, Return on Capital Employed [ROCE] came in at -292.75% in FY2023 (-239.20 pp), -53.56% in FY2022 (+10.06 pp), -63.62% in FY2021 (+216.63 pp) and -280.26% in FY2020 (+304.84 pp).
  • The Q3 2025 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q4 2023.
  • Year over year, Return on Capital Employed [ROCE] gained in five of the last eight quarters, with an average year-over-year change of +81.66 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2024 (a gain of 11715.30 percentage points); the low point was Q4 2023 (a drop of 11678.81 percentage points).
  • Per Business Quant data, the three quarters before Q3 2025 came in at -56.25% (Q2 2025), -43.20% (Q1 2025) and -32.87% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 Corbus Pharmaceuticals Holdings 50.77 Mn -465.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -75.77%
Jun 30, 2025 -56.25%
Mar 31, 2025 -43.20%
Dec 31, 2024 -32.87%
Sep 30, 2024 -31.56%
Jun 30, 2024 -35.00%
Mar 31, 2024 -73.22%
Dec 31, 2023 -11,748.17%
Sep 30, 2023 -540.96%
Jun 30, 2023 -142.07%
Mar 31, 2023 -108.95%
Dec 31, 2022 -69.36%
Sep 30, 2022 -64.55%
Jun 30, 2022 -61.07%
Mar 31, 2022 -56.70%
Dec 31, 2021 -57.93%
Sep 30, 2021 -64.89%
Jun 30, 2021 -77.84%
Mar 31, 2021 -110.99%
Dec 31, 2020 -182.84%
API Access

Corbus Pharmaceuticals Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRBP&period=max&api_key=YOUR_API_KEY